Jin Seok Ahn

Jin Seok Ahn

UNVERIFIED PROFILE

Are you Jin Seok Ahn?   Register this Author

Register author
Jin Seok Ahn

Jin Seok Ahn

Publications by authors named "Jin Seok Ahn"

Are you Jin Seok Ahn?   Register this Author

100Publications

2693Reads

38Profile Views

Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea.

Cancer Res Treat 2020 Jan 26;52(1):292-300. Epub 2019 Jul 26.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2019.1
Publisher Site
http://dx.doi.org/10.4143/crt.2019.186DOI Listing
January 2020

Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease.

Int J Cancer 2019 11 25;145(9):2433-2439. Epub 2019 Mar 25.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32235DOI Listing
November 2019

Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.

Clin Lung Cancer 2019 Nov 21. Epub 2019 Nov 21.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.11.006DOI Listing
November 2019

Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing.

Eur J Cancer 2019 Oct 4;120:65-74. Epub 2019 Sep 4.

Division of Hematology-Oncology, Departments of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049193044
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2019.08.001DOI Listing
October 2019

Clinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy.

Korean J Intern Med 2019 Sep 16;34(5):1100-1106. Epub 2018 Mar 16.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2017.226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718770PMC
September 2019

DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLC.

J Thorac Oncol 2019 Sep 22;14(9):1640-1650. Epub 2019 May 22.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Health Science and Technology, Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.014DOI Listing
September 2019

Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor.

J Thorac Oncol 2019 Sep 11;14(9):1608-1618. Epub 2019 Jun 11.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.033DOI Listing
September 2019

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.

J Clin Oncol 2019 Aug 15;37(24):2162-2170. Epub 2018 Jun 15.

3Samsung Medical Center, Sunghyunkwan University School of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.3184DOI Listing
August 2019

Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma.

Lung Cancer 2019 Aug 24;134:7-15. Epub 2019 May 24.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.024DOI Listing
August 2019

Predictive and Prognostic Value of F-fluorodeoxyglucose Uptake Combined with Thymidylate Synthase Expression in Patients with Advanced Non-Small Cell Lung Cancer.

Sci Rep 2019 Aug 21;9(1):12215. Epub 2019 Aug 21.

Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-48674-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704155PMC
August 2019

Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT).

Support Care Cancer 2019 Jul 23. Epub 2019 Jul 23.

Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04982-zDOI Listing
July 2019

Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor.

Clin Lung Cancer 2019 05 31;20(3):215-221. Epub 2018 Dec 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304183035
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2018.12.020DOI Listing
May 2019

Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma.

J Cancer Res Clin Oncol 2019 May 21;145(5):1341-1349. Epub 2019 Mar 21.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-02889-0DOI Listing
May 2019

Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma.

J Immunother Cancer 2019 May 16;7(1):128. Epub 2019 May 16.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-Gu, Seoul, 60351, Republic of Korea.

View Article

Download full-text PDF

Source
https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0
Publisher Site
http://dx.doi.org/10.1186/s40425-019-0609-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524245PMC
May 2019

Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.

Invest New Drugs 2019 May 24. Epub 2019 May 24.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-019-00795-3DOI Listing
May 2019

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.

Cancer Res Treat 2019 Apr 13;51(2):502-509. Epub 2018 Jun 13.

Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473268PMC
April 2019

Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry.

Tuberc Respir Dis (Seoul) 2019 Apr 19;82(2):118-125. Epub 2018 Jun 19.

Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4046/trd.2017.0128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435924PMC
April 2019

Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea.

Cancer Res Treat 2019 Apr 23;51(2):623-631. Epub 2018 Jul 23.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2018.1
Publisher Site
http://dx.doi.org/10.4143/crt.2018.151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473281PMC
April 2019

The First-week Proliferative Response of Peripheral Blood PD-1CD8 T Cells Predicts the Response to Anti-PD-1 Therapy in Solid Tumors.

Clin Cancer Res 2019 04 15;25(7):2144-2154. Epub 2019 Jan 15.

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-1449DOI Listing
April 2019

Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancer.

Lung Cancer 2019 04 28;130:87-92. Epub 2019 Jan 28.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.01.012DOI Listing
April 2019

Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer.

Eur J Nucl Med Mol Imaging 2019 02 25;46(2):446-454. Epub 2018 Aug 25.

Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-018-4138-5DOI Listing
February 2019

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-Mutated Advanced NSCLC.

J Thorac Oncol 2019 02 1;14(2):193-202. Epub 2018 Nov 1.

Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183338
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.10.150DOI Listing
February 2019

Clinical features and prognosis of breast cancer with gastric metastasis.

Oncol Lett 2019 Feb 23;17(2):1833-1841. Epub 2018 Nov 23.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.

View Article

Download full-text PDF

Source
http://www.spandidos-publications.com/10.3892/ol.2018.9754
Publisher Site
http://dx.doi.org/10.3892/ol.2018.9754DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341777PMC
February 2019

Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer.

Cancer Res Treat 2019 Jan 23;51(1):408-412. Epub 2018 May 23.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333983PMC
January 2019

A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.

Breast Cancer Res Treat 2019 Jan 15;173(2):255-266. Epub 2018 Oct 15.

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4981-x
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4981-xDOI Listing
January 2019

Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea.

BMC Cancer 2019 Jan 17;19(1):84. Epub 2019 Jan 17.

Division of Hematology-Oncology, Departments of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-5258-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337867PMC
January 2019

Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis.

J Breast Cancer 2018 Dec 29;21(4):382-390. Epub 2018 Oct 29.

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4048/jbc.2018.21.e48DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310726PMC
December 2018

Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment.

Clin Breast Cancer 2018 10 19;18(5):e1141-e1147. Epub 2018 Apr 19.

Statistics and Data Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.04.010DOI Listing
October 2018

Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort.

Breast Cancer Res Treat 2018 Oct 21;171(3):737-745. Epub 2018 Jun 21.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-018-4858-z
Publisher Site
http://dx.doi.org/10.1007/s10549-018-4858-zDOI Listing
October 2018

Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial.

Lung Cancer 2018 10 3;124:293-297. Epub 2018 Aug 3.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183051
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.08.003DOI Listing
October 2018

Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice.

J Thorac Oncol 2018 09 5;13(9):1373-1382. Epub 2018 Jun 5.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.05.026DOI Listing
September 2018

Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication.

J Thorac Oncol 2018 08;13(8):1106-1112

Division of Hematology-Oncology, Departments of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.038DOI Listing
August 2018

Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma.

Lung Cancer 2018 08 9;122:160-164. Epub 2018 Jun 9.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002183041
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2018.06.009DOI Listing
August 2018

Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model.

PLoS One 2018 11;13(4):e0194730. Epub 2018 Apr 11.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0194730PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895014PMC
July 2018

Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy?

J Breast Cancer 2018 Jun 20;21(2):206-212. Epub 2018 Jun 20.

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4048/jbc.2018.21.2.206DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015985PMC
June 2018

Afatinib in heavily pretreated advanced NSCLC patients who progressed following prior gefitinib or erlotinib: Compassionate use program in Korea.

Lung Cancer 2018 05 6;119:36-41. Epub 2018 Mar 6.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.02.020DOI Listing
May 2018

Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer.

Oncoimmunology 2018 24;7(8):e1466768. Epub 2018 May 24.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2018.1466768DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136852PMC
May 2018

Distress and body image due to altered appearance in posttreatment and active treatment of breast cancer patients and in general population controls.

Palliat Support Care 2018 04 6;16(2):137-145. Epub 2017 Mar 6.

Departments of Health Sciences and Technology and Clinical Research Design and Evaluation,Samsung Advanced Institute of Health Sciences and Technology,Sungkyunkwan University,Seoul,Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1478951517000062DOI Listing
April 2018

KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma.

J Thorac Oncol 2018 03 2;13(3):e29-e31. Epub 2017 Nov 2.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.10.014DOI Listing
March 2018

Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07).

Br J Cancer 2018 03 30;118(5):648-653. Epub 2018 Jan 30.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.465DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846070PMC
March 2018

Late-Onset Cholecystitis with Cholangitis after Avelumab Treatment in Non-Small Cell Lung Cancer.

J Thorac Oncol 2018 03;13(3):e34-e36

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.10.007DOI Listing
March 2018

Temporal and regional distribution of initial recurrence site in completely resected N1-stage II lung adenocarcinoma: The effect of postoperative adjuvant chemotherapy.

Lung Cancer 2018 03 6;117:7-13. Epub 2018 Jan 6.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.01.004DOI Listing
March 2018

Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy.

J Breast Cancer 2018 Mar 23;21(1):91-95. Epub 2018 Mar 23.

Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4048/jbc.2018.21.1.91DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880971PMC
March 2018

Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer.

J Thorac Oncol 2018 01 31;13(1):106-111. Epub 2017 Oct 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.10.011DOI Listing
January 2018

Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer.

Lung Cancer 2018 01 22;115:89-96. Epub 2017 Nov 22.

Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.11.020DOI Listing
January 2018

Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer.

J Thorac Oncol 2017 12 28;12(12):1806-1813. Epub 2017 Sep 28.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.09.1954DOI Listing
December 2017

An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer.

Expert Rev Mol Diagn 2017 10 30;17(10):933-942. Epub 2017 Aug 30.

b Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center , Sungkyunkwan University School of Medicine , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2017.1372196DOI Listing
October 2017

Comparison of RECIST to immune-related response criteria in patients with non-small cell lung cancer treated with immune-checkpoint inhibitors.

Cancer Chemother Pharmacol 2017 Sep 21;80(3):591-598. Epub 2017 Jul 21.

Division of Hematology-Oncology, Departments of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3396-4DOI Listing
September 2017

Mutational status of defines the efficacy of Wee1 inhibitor AZD1775 in -mutant non-small cell lung cancer.

Oncotarget 2017 Sep 28;8(40):67526-67537. Epub 2017 Jun 28.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620191PMC
September 2017

Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy.

Asia Pac J Clin Oncol 2017 Aug 21;13(4):329-336. Epub 2016 Nov 21.

Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12652DOI Listing
August 2017

A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy.

Breast Cancer Res Treat 2017 Aug 9;164(3):617-625. Epub 2017 May 9.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4268-7DOI Listing
August 2017

Immune signature of metastatic breast cancer: Identifying predictive markers of immunotherapy response.

Oncotarget 2017 Jul;8(29):47400-47411

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.17653DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564574PMC
July 2017

EGFR TKI combination with immunotherapy in non-small cell lung cancer.

Expert Opin Drug Saf 2017 Apr 8;16(4):465-469. Epub 2017 Mar 8.

a Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center , Sungkyunkwan University School of Medicine , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1300656DOI Listing
April 2017

Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes.

Oncotarget 2017 Apr;8(17):27997-28007

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.15881DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438625PMC
April 2017

Osimertinib for the treatment of non-small cell lung cancer.

Expert Opin Pharmacother 2017 Feb;18(2):225-231

a Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center , Sungkyunkwan University School of Medicine , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1285283DOI Listing
February 2017

Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period.

J Pathol Transl Med 2017 Jan 25;51(1):69-78. Epub 2016 Dec 25.

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://jpatholtm.org/journal/view.php?doi=10.4132/jptm.2016.
Publisher Site
http://dx.doi.org/10.4132/jptm.2016.10.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267543PMC
January 2017

Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems.

Breast Cancer Res Treat 2016 12 11;160(3):475-489. Epub 2016 Oct 11.

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-4008-4DOI Listing
December 2016

Transient Asymptomatic Pulmonary Opacities during Osimertinib Treatment: "Stop or Go" Decision.

J Thorac Oncol 2016 12;11(12):2051-2052

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.09.130DOI Listing
December 2016